|
| 武汉地区33家医院2008～2010年5-HT3受体拮抗药应用分析 |
| Analysis of 5-HT3Receptor Antagonists in Wuhan Area during the Period 2008-2010 |
| 投稿时间：2011-06-04 |
| DOI： |
| 中文关键词: 5-HT3受体拮抗药 限定日剂量 用药频度 日用药金额 |
| 英文关键词:5-HT3receptor antagonists Defined daily dose DDDs Daily drug cost |
| 基金项目: |
|
| 摘要点击次数: 1238 |
| 全文下载次数: 1404 |
| 中文摘要: |
| 摘 要 目的：研究5-HT3受体拮抗药在武汉地区的应用情况和发展趋势。 方法：采用世界卫生组织推荐的限定日剂量为指标的分析方法，对武汉地区33家医院2008~2010年5-HT3受体拮抗药有关数据进行统计分析。结果：5-HT3受体拮抗药销售金额逐年增加，托烷司琼使用频度的构成比最高，帕洛诺司琼的销售金额与使用频度增长迅速。结论：第一代5-HT3受体拮抗药仍然是化疗呕吐治疗的一线用药，第二代5-HT3受体拮抗药在治疗化疗呕吐领域越来越受到重视。 |
| 英文摘要: |
| ABSTRACT Objective:To evaluate the current situation and the developing trend of 5-HT3receptor antagonists used in 33 hospital of Wuhan during the period of 2008-2010. Method:The 5-HT3receptor antagonists were statistically analyzed in respect to consumption sum，DDDs and daily costs.Result:During the 3 years，consumption sum of 5-HT3receptor antagonists were yearly increasing．Tropisetron ranked the first in constituent ratios of consumption sum. The market of palonosetron showed a rapid increasing tendency. Conclusion:The first generation 5-HT3 receptor antagonists are the first choice drugs in the clinic, while the second generation 5-HT3 receptor antagonists will be gradually accepted by doctors. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
